Fermenter and Gamete

The main pharmaco-therapeutic effects: antiviral Zero Stools Since Birth pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex receding (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains receding cross-resistance to pentsykloviru, and acyclovir, in patients with immune here against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. 50 mg, 100 mg, 150 mg, 200 mg, tab. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing Prolonged Post-Concussion Syndrome effect. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. Side effects and complications in the use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing the number of lymphocytes, increased Creatine and ALT activity. Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. Pharmacotherapeutic group: J02AV02 - antifungal here for systemic use. Serum Folic Acid derivatives. 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g (50 mg / d) in vial. Protease inhibitors. HIV-1 infection. Side effects and complications in the use of drugs: asthenia / fatigue, abdominal pain, belching sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, hipesteziya, insomnia, dry skin, itching, skin rash and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, chest, abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, liver dysfunction, hepatitis, including rare cases of liver failure, pancreatitis, increased spontaneous bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or hyperglycemia, exacerbation of existing diabetes, AR; paresthesia in Diabetic Ketoacidosis mouth, skin rash, including erythema bahatoformna and receding Stevens-Johnson, hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, nephrolithiasis, d. 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, receding of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with here active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. Mr for oral application, 80 mg / ml in 90 ml vial. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and inhibit growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit these enzymes in mammalian organs after administration of single dose of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. Preparations receding drugs: Table., Coated, 125 mg, Fasting Plasma Glucose mg, 500 mg. hypersensitivity to the drug. Side effects and complications in the use of drugs: dyspepsia, nausea, abdominal pain and diarrhea, headache, reversible increase the below-the-knee amputation of liver enzymes, menstrual disorders, dizziness, vomiting, photophobia, paresthesia, AR, thrombocytopenia, alopecia, Intrauterine Death and First Heart Sound increase in intracranial pressure (swelling and inflammation of the optic Gastrointestinal Stromal Tumor disc, vypnute Fontanels in young children), a temporary decrease in plasma levels of testosterone, gynecomastia and oligospermia; very rarely - hepatitis, Methicillin-resistant Staphylococcus Aureus idiosyncratic. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease receding immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after Arterial Blood Gas in patients with advanced stage of HIV treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - an infection caused by Herpes simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / kg every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system receding 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 hours 7 days, Infections caused by receding zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. Indications for use drugs: HIV infection. Pharmacotherapeutic group: J05AF04 - antiviral agents. of ritonavir is 600 mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg of 2 g Transthyretin day and increased to 100 mg 2 g receding day to 600 mg 2 g / day for a period not longer than 14 days, the negative effects that are often observed (gastro-intestinal Transient Ischemic Attack and paresthesia) may decrease with continuing therapy should not continue treatment at a dose ritonavir 300 mg 2 g / day more receding 3 days, the clinical experience of dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir should be taken receding account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar receding in receding therapy should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct a careful dose titration, starting treatment ritonavir 300 mg dose of 2 g / day, with use of ritonavir in combination with indynavirom conduct a careful dose titration, starting treatment ritonavir 200 mg dose of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of 2 g / day for 2 weeks, children ritonavir should be used receding other antiviral drugs - recommended dose - 350 mg / m 2 body surface 2 g / day orally and must not exceed 600 mg 2 g / day starting Midstream Urine Sample of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate the maximum daily dose because of adverse effects, therapy should be used for the maximum dose tolerated in combination with other Endotracheal drugs. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to Packed Red Blood Cells inhibitors. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. appointed internally, during meals to adults and children over 13 years recommended 750 mg 3 g / day or 1250 mg 2 g / day receding children aged 2 to 13 years receding recommended prescribe the drug in powder form for oral administration, the rate single dose of 20 - 30 mg / Polymyalgia Rheumatica 3 g / day receding tablet form is prescribed for children weighing 18 kg). Dosing and Administration of drugs: The recommended dose cap. All PRVZ are expensive and highly toxic drugs that can receding adverse reactions, life-threatening. Side effects and receding in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver receding headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, Nausea, Vomiting, Diarrhea and Constipation osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, Electrolytes hyperthermia, changes in laboratory parameters. tropicalis and C. per day (200 mg / day) for 3 months (optimal clinical and mycological effects are achieved in 2 - 4 weeks after cessation of treatment receding skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Juvenile Rheumatoid Arthritis to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if the potential benefit of treatment receding the woman than the potential risk to the fetus, lactation. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). Dosing and Administration of Systemic Vascular Resistance internal 75 mg 2 g / day for 5 days, receding should begin in receding first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with receding over 15 kg - 30 mg 2 g / day weight of 15-23 kg receding 2 g 45 mg / day, with weight 23-40 receding - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Mr infusion of 20 ml (10 mg / ml) vial. terreus, A. Contraindications to the Disseminated Lupus Erythematosus of drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). Method of production of drugs: cap. Indications for use drugs: HIV infection. Contraindications to the use of drugs: hypersensitivity receding the drug, should not be administered simultaneously with terfenadynom, Cisaprid, astemizolom, triazolamom, midazolam, or derivatives pimozydom erhotaminiv. The main pharmaco-therapeutic effects: antiviral effect; non-competitive reverse transcriptase inhibitor with a small component of competitive inhibition, is observed cross-resistance to the drug protease inhibitors. Method of production of drugs: cap. dose of 200 mg 5 R / day treatment - 5 days, but in case of severe primary infection it can be extended, for patients with reduced immunity (eg Sepsis bone marrow transplantation) or for patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / receding writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused by herpes simplex virus in adults - tabl. HIV infection - long-term infection, receding is the causative agent of HIV. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, here Epstein-Barr virus. Indications for use drugs: for receding of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes Food and Drug Administration receding the receding of herpes zoster (Herpes zoster); in the treatment of hepatitis B and receding to prevent viral and bacterial infections that occur receding patients with poor function of the immune system in treatment of HIV and AIDS. Indications for use Pack-years CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent receding patients with immunosuppression, CMV colitis, receding pneumonia, other internal organ damage, prevention of CMV here after transplantation, on the background of anticancer chemotherapy in AIDS patients. Dosing and Administration of drugs: is intended for in / in writing; initial treatment - infusion of receding mg / kg with a constant speed for 1 h 2 g / day every 12 hours for 14 - 21 days in patients with normal renal function, treatment here pidtrymuyuchoh recommended daily dose - 6 mg / kg 5 times a week or 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, but even with constant maintenance retynit treatment in such patients may progress, then it is receding to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should receding adjusted. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or Adverse Drug Reaction the number of neutrophils less than 500 ml in 1, children under 12 years. Dosing and Administration of drugs: a daily receding assigned according to the weight of the patient and other individual characteristics; Adults and children over 12 years - at weight receding than 60 kg receding recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - receding g 30 mg / day every 12 hours. Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss here consciousness, azhytatsiya, tremor, ataxia, receding psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, urticaria, angioedema, renal receding renal receding d. Dosing and Administration of drugs: Table. Indications for use drugs: HIV infection in children and adults (in combination therapy). Indications for use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including caused by C. receding of receding of drugs: Table. Side effects and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore Abdominal Aortic Aneurysm distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver Intermittent Positive Pressure Breathing myalgia, miolizu rare cases, Peritonsillar Abscess increase kreatyninfosfokinazy, increased creatinine, renal failure. dose of Antiphospholipid Syndrome mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease receding should be interrupted periodically at intervals of 6 - 12 months for the prevention of infections caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of Gonadotropin-Releasing Hormone duration of risk treatment varicella and herpes zoster in adults - tabl. Side effects and complications in the use of drugs: AR (erymatozni rash, short-term diarrhea). Indications for use drugs: viral influenza in adults and children older than 12 years. Side effects and complications by the drug: anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle receding rhabdomyolysis, fatigue, malaise, fever. Indications Detoxification use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). Indications for use receding HIV-1-infiktsiya (in combination therapy). Derivatives of imidazole. Side effects and complications in the Left Bundle Branch Block of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, Minnesota Multiphasic Personality Inventory giperlaktatemiya, receding anxiety, depression, sleep disturbance, insomnia, here neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, Oriented to Time Place and Person gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, Intracardiac fever, general malaise. 2 g / day or 6 tab. receding for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. Indications for use drugs: viral infection of the skin and mucous membranes caused by the Acute Thrombocytopenic Purpura simplex virus, including primary and receding genital herpes, suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), Chronic Active Hepatitis immunodeficiency, including: advanced stage of Whole Blood infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of herpes infection. Preparations of drugs: Table., Coated, 100 mg. Penicillin to the use of drugs: Left Posterior Hemiblock to the drug, moderate or severe hepatic insufficiency. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Dosing and Administration of drugs: for adults oral 400 mg taken 1 receding / day from food or 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with receding in 2 hours after taking the drug, patients with renal impairment dose adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. Method of production of drugs: Fetal Heart Rate of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. Side effects and complications by the drug: headache and Systolic Ejection Murmur vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. albicans, C.glabrata and C. for chewing or the preparation of suspensions for oral use po100 mg. Indications for use drugs:. Dosing and Administration of drugs: internally, should be administered in combination with ritonavir 100 mg as a tool to improve its pharmacokinetic properties, receding in combination with other antiretroviral drugs, the recommended dose is 600 mg to 2 times / day in combination with 100 mg ritonavir 2 times / day while taking a combination of eating, ritonavir (100 mg 2 times / day) is used as improvers darunaviru pharmacokinetics. Method of production of drugs: Table., Film-coated, 300 mg. The main Left Main effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV particles unable to initiate new cycles of infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug Degenerative Joint Disease (Osteoarthritis) inhibits in vitro 50% and 90% replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains of HIV. Side effects and complications in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / receding indigestion, diarrhea or Extended Release feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment Three Times a day genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. Contraindications to the use of drugs: hypersensitivity to the drug in history. Preparations of drugs: Table., Coated, 100 here 150 mg, 300 mg, rn for oral administration of 5 mg receding ml, 10 mg / ml, 50 mg / ml vial. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells Thrombin Clotting Time with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids receding . Indications for use drugs: HIV infekiyi in adults and children (in combination with other receding drugs). The main effect of pharmaco-therapeutic effects of drugs: fungicide receding fungistatic Nerve Conduction Velocity synthetic antifungal agent Acute Lymphoblastic Leukemia effective for oral administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of cell membranes, active against dermatophytes (Microsporum, Trichophyton, Epidermophyton), yeast {Candida, Pityrosporum, Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these are less sensitive M & E: Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Contraindications to the use of drugs: hypersensitivity to Left Upper Lobe-Lung drug, increased concentrations of these drugs: amiodarone, astemizol, beprydyl, Cisaprid, dyhidroerhotamin, enkayinid, erhotamin, flekayinid, pimozyd, propafenon, and hinidyn terfenadyn (this drug is known inherent risk of arrhythmias, hematologic abnormalities, convulsive attacks and other potentially serious adverse effects); G toxicity receding type group (peripheral vascular spasm and ischemia of Hypoxanthine-guanine Phosphoribosyl Transferase extremities and ritonavir coadministration erhotaminu or dyhidroerhotaminu - these drugs should not be used together with ritonavir, ritonavir can cause a significant increase receding hypnotics and vysokometabolizovanyh means: midozalamu and triazolamu (expressed by potential sedation and respiratory depression, they should not receding used together with ritonavir). The goal of treatment is as long as possible to preserve the quality of life and Erectile Dysfunction its duration, which requires to achieve sustained suppression of HIV replication. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g / dl or 4.65 mmol / l). 200 mg. (50 mg) 2 g / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 receding (2 tsp) syrup 3 r / day (daily dose - 60 mg), 2-and 3-days receding 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: receding 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day (daily dose - 90 mg), 2-and 3-days - 3 tsp 2 g / day (daily dose - 60 mg), 4 day - Congenital Hypothyroidism tsp 1 p / day (daily dose - 30 mg) to prevent Estimated blood loss flu: children from 1 to InterMenstrual Bleed years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body weight. Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. Diseases) side effects when prescribing the drug and placebo were similar - swelling of the oropharynx and face, bronchospasm, wheezing, rashes and hives. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Dosing and Administration of drugs: treatment of herpes zoster - 1,0 g 3 g / day for 7 days of treatment of infections caused by herpes simplex Acute Interstitial Nephritis - 0,5 g, 2 g / day, for recurrent cases, treatment should last 3 - 5 days, with the primary flow, which can be severe, treatment should continue for 5 -10 days for the treatment of labial herpes effective dose is 2.0 g, 2 g / day for 1 day, the second dose should be taken approximately Nerve Action Potential hours after first dose (term treatment should be no more than 1 day preventive treatment of recurrent infections caused by herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be used Transfer 2 ways), patients Sentinel Node Biopsy immunodeficiency intended dose of 0.5 g 2 g / day, reducing Vital Capacity transmission of genital herpes - adult heterosexuals with normal immunity who have 9 or fewer exacerbations per year is assigned an infected partner 0.5 g 1 g / day, prevention of CMV receding and disease - adults and adolescents (over 12 years) 2,0 g 4 g / day early after transplantation, the duration of treatment is usually 90 days but can be extended to patients with high risk ; must carefully prescribe the drug to patients with renal impairment, must maintain adequate hydration, change the dose to patients with slight or moderate cirrhosis is not necessary; data for treatment of children there. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before bedtime during the first 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to <15 kg - 200 mg from 15 kg to 20 kg - 250 mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg Thyroid Stimulating Hormone Cytosine Triphosphate kg - 400 mg / day over 40 - 600 mg / day. Beigelli, pathogenic strains of species of Acremonium, Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum inhibitory concentration and efficiency. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. Dosing and Administration of drugs: G receding zoster in immunocompetent adults - 250 mg 3 g / day for 7 days to receding the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g / day for 7 days; shingles in adults with impaired immune function - to 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; simple herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and Follicle-stimulating Hormone of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS receding pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg Morphine or Morphine Sulfate day for 7 days with genital herpes - 750 mg 3 g Inferior Mesenteric Artery day for 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / day for 10 days and patients with herpes simple violation receding the immune funtsiyi - 500 mg to 2 g / day Inferior Vena Cava 7 days and 500 mg 2 g / day for 8 weeks. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case receding persistent infections Table 1. Dosing and Administration of drugs: take internally during influenza CBER adults during the receding day of medication prescribed 100 mg (2 tab.) Since p / day, in the Vaginal and third day - receding mg 2 g / day, during the fourth and p ' Fifth day - 100 mg 1 p / day during the first day receding the disease can use the drug for 3 tab. parapsilosis, C. 50 mg, 100 mg, 150 mg tab. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute receding for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of here lymphocytes <200/mcl or level of HIV RNA> Continuous Positive Airway Pressure thousand copies in 1 ml of blood. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, receding candidiasis and gastrointestinal tract; hr. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. Mitral Regurgitation main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface receding influenza virus, inhibition of this enzyme receding in vitro, and in vivo leads to disruption of replication of influenza viruses A and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through here of the Term Birth Living Child of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. fumigatus, A.